Agency Information Collection Activities: Proposed Collection; Comment Request, 7776-7778 [2020-02671]
Download as PDF
<![CDATA[
7776
Federal Register / Vol. 85, No. 28 / Tuesday, February 11, 2020 / Notices
Dated: February 5, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
khammond on DSKJM1Z7X2PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Initial Review Group; Diabetes,
Endocrinology and Metabolic Diseases B
Subcommittee DDK–B Subcommittee.
Date: March 11–13, 2020.
Time: 5:30 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, Conference
Room Rooftop, One Bethesda Metro Center,
7400 Wisconsin Avenue, Bethesda, MD
20814.
Contact Person: Charlene J. Repique, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7347, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–7791,
charlene.repique@nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Initial Review Group; Digestive Diseases and
Nutrition C Subcommittee DDK–C
Subcommittee.
Date: March 12–13, 2020.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, Conference
Room Embassy/Potomac, 7335 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Maria E. Davila-Bloom,
Ph.D., Scientific Review Officer, Review
Branch, Division of Extramural Activities,
NIDDK, National Institutes of Health, Room
7017, 6707 Democracy Boulevard, Bethesda,
MD 20892–5452, (301) 594–7637, davilabloomm@extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
VerDate Sep<11>2014
18:19 Feb 10, 2020
Jkt 250001
[FR Doc. 2020–02635 Filed 2–10–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Nutrition Obesity
Research Centers (P30).
Date: March 9–10, 2020.
Time: 8:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, Conference
Room Embassy/Potomac, 7335 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Thomas A. Tatham, Ph.D.,
Scientific Review Officer, Review Branch,
Division of Extramural Activities, NIDDK,
National Institutes of Health, Room 7021,
6707 Democracy Boulevard, Bethesda, MD
20892–5452, (301) 594–3993, tathamt@
mail.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Integrating Large
Scale Genomics and Functional Studies to
Accelerate FSGS/NS Discovery.
Date: March 11, 2020.
Time: 12:00 p.m. to 1:15 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Paul A. Rushing, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7345, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–8895,
rushingp@extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
Special Emphasis Panel; Application of
Progenitor Niche Signals to Ex Vivo
Nephrogenesis.
Date: March 12, 2020.
Time: 3:00 p.m. to 4:15 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Paul A. Rushing, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7345, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–8895,
rushingp@extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: February 5, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–02639 Filed 2–10–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Proposed Collection;
Comment Request
In compliance with Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 concerning the
opportunity for public comment on
proposed collections of information, the
Substance Abuse and Mental Health
Services Administration (SAMHSA)
will publish periodic summaries of
proposed projects. To request more
information on the proposed projects or
to obtain a copy of the information
collection plans, call the SAMHSA
Reports Clearance Officer at (240) 276–
0361.
Comments are invited on: (a) Whether
the proposed collections of information
are necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
E:\FR\FM\11FEN1.SGM
11FEN1
7777
Federal Register / Vol. 85, No. 28 / Tuesday, February 11, 2020 / Notices
of automated collection techniques or
other forms of information technology.
Proposed Project: Mandatory
Guidelines for Federal Workplace Drug
Testing Programs (OMB No. 0930–
0158)—Revision
SAMHSA will request OMB approval
for a revision of the Federal Drug
Testing Custody and Control Form
(CCF) for federal agency and federally
regulated drug testing programs which
must comply with the HHS Mandatory
Guidelines for Federal Workplace Drug
Testing Programs using Urine (UrMG)
dated January 23, 2017 (82 FR 7920) and
using Oral Fluid (OFMG) dated October
25, 2019, and OMB approval for
information provided by test facilities
(laboratories and Instrumented Initial
Test Facilities, IITFs) for the National
Laboratory Certification Program
(NLCP).
The CCF is used by all federal
agencies and employers regulated by the
Department of Transportation (DOT)
and the Nuclear Regulatory Commission
(NRC) to document the collection and
chain of custody of urine specimens at
the collection site, for HHS-certified test
facilities to report results, and for
Medical Review Officers (MROs) to
document and report a verified result.
SAMHSA allows the use of the CCF as
a paper or electronic form.
The current OMB-approved CCF has
an August 31, 2020 expiration date.
SAMHSA has resubmitted the CCF with
major content revisions to the form for
OMB approval. These revisions are:
Copies 1–5
Revised Step 1
1. Added ‘‘Collector Contact Info:’’ and
‘‘Other’’ line (e.g., email)
Revised Step 2
1. Put Urine and Oral Fluid checkboxes
above Step 2 for collector to
annotate
2. Expanded to 4 lines for collector
entries:
—General entry for Split, Single, or
None Provided (same as current)
—Entries specific to urine collection
(moved ‘‘Collector reads urine
temperature within 4 minutes’’
here; other entries same as current)
—Entries specific to oral fluid
collection: added ‘‘Split Type’’ with
checkboxes for Serial, Concurrent,
and Subdivided; ‘‘Each Device
Within Expiration Date?’’ with
checkboxes Yes or No; and Volume
Indicator(s) Observed checkbox)
—Remarks (same as current)
Revised Step 3
1. Edited instruction to state ‘‘collector
affixes seal(s) to bottle(s)/tube(s)’’
Revised Step 4 (Collector Section)
1. Edited ‘‘Specimen Bottle(s) Released
To’’ box to state ‘‘Specimen
Bottle(s)/Tubes(s) Released To’’
Copy 1 (Test Facility Copy)
Revised Step 4 (Accessioner Section)
1. Edited ‘‘Specimen Bottle(s) Released
To’’ box to state ‘‘Specimen
Bottle(s)/Tubes(s) Released To’’
2. Added ‘‘Primary/Single Specimen
Device Expiration Date’’ and ‘‘Split
Specimen Device Expiration Date’’
fields for accessioner to annotate
expiration dates of oral fluid
collection devices
Revised Step 5a (Certification and
Reporting Section)
1. Removed analyte names and
checkboxes
2. Repositioned results and checkboxes:
Moved REJECTED FOR TESTING,
ADULTERATED, SUBSTITUTED
and INVALID RESULT checkboxes;
moved POSITIVE checkbox to be
under DILUTE
3. Added line for certifying scientist to
record positive analytes and
concentrations, and added
‘‘Analyte(s) in ng/mL’’ instruction
(aligned under ‘‘POSITIVE for:’’)
Copy 2 (Medical Review Officer Copy)
Revised Step 6 (Donor Section)
1. Edited donor certification statement
to state ‘‘specimen bottle/tubes’’
Revised Step 7 (MRO Section—Primary
Specimen)
1. Put Urine and Oral Fluid checkboxes
above Step 6 for MRO to annotate
khammond on DSKJM1Z7X2PROD with NOTICES
Custody and Control Form: 1
Donor ............................................................................
Collector ........................................................................
Laboratory .....................................................................
IITF ................................................................................
Medical Review Officer .................................................
NLCP Application Form: 2
Laboratory .....................................................................
VerDate Sep<11>2014
18:19 Feb 10, 2020
Jkt 250001
Responses
per
respondent
Number of
respondents
Form/respondent
PO 00000
Frm 00065
Bottom of Copies
Revised Copy 1
1. Edited label/seal at bottom of Copy 1
to allow for modification (e.g.,
perforations, label with transparent
seal on one side, and separate label
and seal)
Revised Copies 3–5
1. Removed Steps 6 and 7 (MRO
sections)
2. Moved Public Burden Statement from
the back to the front of the copies
Additional Edits to Copy 5
1. Moved Privacy Act Statement (for
federal employees) from the back to
the front of the copy
2. Removed Instructions for Completing
the CCF from the back. SAMHSA
will post instructions for
completing the Federal CCF for
urine and oral fluid on their
website.
Based upon information from federal
agencies and from DOT concerning their
regulated industries, the number of
respondents has increased from 5.4
million to 6.7 million, which increases
the total burden hours by 170,701.8.
Laboratories and IITFs seeking HHS
certification under the NLCP must
complete and submit the NLCP
application form. The NLCP application
form has not been revised compared to
the previous form.
Prior to an inspection, an HHScertified laboratory or IITF is required to
submit specific information regarding
its procedures. Collecting this
information prior to an inspection
allows the inspectors to thoroughly
review and understand the testing
procedures before arriving for the onsite
inspection. The NLCP information
checklist has not been revised compared
to the previous form.
The annual total burden estimates for
the CCF, the NLCP application, the
NLCP information checklist, and the
NLCP recordkeeping requirements are
shown in the following table.
Total
number of
responses
Burden
per response
(hours)
Annual
burden
(hours)
6,726,610
6,726,610
6,726,610
1
6,726,610
1
1
1
0
1
6,726,610
6,726,610
6,726,610
0
6,726,610
0.08
0.07
0.05
0.05
0.05
538,128.8
378,000
336,330
0
270,000
5
5
5
3
15
Fmt 4703
Sfmt 4703
E:\FR\FM\11FEN1.SGM
11FEN1
7778
Federal Register / Vol. 85, No. 28 / Tuesday, February 11, 2020 / Notices
IITF ................................................................................
Sections B and C—NLCP Inspection Checklist:
Laboratory .....................................................................
IITF ................................................................................
Record Keeping:
Laboratory .....................................................................
IITF ................................................................................
Total .......................................................................
Send comments to Carlos Graham,
SAMHSA Reports Clearance Officer,
Room 15–E–57–A, 5600 Fishers Lane,
Rockville, MD 20857 OR email a copy
to Carlos.Graham@samhsa.hhs.gov.
Written comments should be received
by April 13, 2020.
Jennifer Wilson,
Budget Analyst.
[FR Doc. 2020–02671 Filed 2–10–20; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
[Docket ID FEMA–2020–0007; OMB No.
1660–0143]
Agency Information Collection
Activities: Proposed Collection;
Comment Request; Federal Emergency
Management Agency Individual
Assistance Customer Satisfaction
Surveys
Federal Emergency
Management Agency, DHS.
ACTION: Notice and request for
comments.
AGENCY:
The Federal Emergency
Management Agency, as part of its
continuing effort to reduce paperwork
and respondent burden, invites the
general public and other Federal
agencies to take the opportunity to
comment on a revision of a currently
approved information collection. In
accordance with the Paperwork
Reduction Act of 1995, this notice seeks
comments concerning the collection of
Individual Assistance customer
satisfaction survey responses and
information for assessment and
improvement of the delivery of disaster
assistance to individuals and
households.
DATES: Comments must be submitted on
or before April 13, 2020.
ADDRESSES: To avoid duplicate
submissions to the docket, please use
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
18:19 Feb 10, 2020
Jkt 250001
Responses
per
respondent
Number of
respondents
Form/respondent
Total
number of
responses
Frm 00066
Annual
burden
(hours)
0
0
0
3
0
29
0
1
0
29
0
1
1
29
0
29
0
1
0
29
0
250
250
7,250
0
6,726,673
........................
26,906,503
........................
1,529,753
only one of the following means to
submit comments:
(1) Online. Submit comments at
www.regulations.gov under Docket ID
FEMA–2020–0007. Follow the
instructions for submitting comments.
(2) Mail. Submit written comments to
Docket Manager, Office of Chief
Counsel, DHS/FEMA, 500 C Street SW,
Room 8NE, Washington, DC 20472–
3100.
All submissions received must
include the agency name and Docket ID.
Regardless of the method used for
submitting comments or material, all
submissions will be posted, without
change, to the Federal eRulemaking
Portal at https://www.regulations.gov,
and will include any personal
information you provide. Therefore,
submitting this information makes it
public. You may wish to read the
Privacy and Security Notice that is
available via the link on the homepage
of www.regulations.gov.
FOR FURTHER INFORMATION CONTACT:
Jessica Guillory, Statistician, Customer
Survey & Analysis Section, Recovery
Directorate, FEMA at Jessica.Guillory@
fema.dhs.gov. You may contact the
Records Management Division for
copies of the proposed collection of
information at email address: FEMAInformation-Collections-Management@
fema.dhs.gov.
SUPPLEMENTARY INFORMATION: This
collection is in accordance with
Executive Orders 12862 and 13571
requiring all Federal agencies to survey
customers to determine the kind and
quality of services they want and their
level of satisfaction with existing
services. The Government Performance
and Results Act (GPRA) requires
agencies to set missions and goals and
measure performance against them and
the GPRA Modernization Act of 2010
requires quarterly performance
assessments of government programs for
the purposes of assessing agency
performance and improvement. FEMA
will fulfill these requirements by
collecting customer satisfaction program
information through surveys of the
PO 00000
Burden
per response
(hours)
Fmt 4703
Sfmt 4703
Recovery Directorate’s external
customers.
Collection of Information
Title: Federal Emergency Management
Agency Individual Assistance Customer
Satisfaction Surveys.
Type of Information Collection:
Revision of a currently approved
information collection.
OMB Number: 1660–0143.
FEMA Forms: FEMA Form 519–0–36,
Initial Survey—Phone, FEMA Form
519–0–37, Initial Survey—Electronic;
FEMA Form 519–0–38, Contact
Survey—Phone, FEMA Form 519–0–39,
Contact Survey—Electronic; FEMA
Form 519–0–40, Assessment Survey—
Phone, FEMA Form 519–0–41,
Assessment Survey—Electronic.
Abstract: Federal agencies are
required to survey their customers to
determine the kind and quality of
services customers want and their level
of satisfaction with those services.
Analysis from the survey is used to
measure FEMA’s Strategic Plan’s
objective 3.1 Streamline the Disaster
Survivor Experience.
Affected Public: Individuals or
households.
Estimated Number of Respondents:
38,864.
Estimated Number of Responses:
38,864.
Estimated Total Annual Burden
Hours: 8,982.
Estimated Total Annual Respondent
Cost: $327,573
Estimated Respondents’ Operation
and Maintenance Costs: $0.
Estimated Respondents’ Capital and
Start-Up Costs: $0.
Estimated Total Annual Cost to the
Federal Government: $1,785,889.
Comments
Comments may be submitted as
indicated in the ADDRESSES caption
above. Comments are solicited to (a)
evaluate whether the proposed data
collection is necessary for the proper
performance of the agency, including
whether the information shall have
practical utility; (b) evaluate the
E:\FR\FM\11FEN1.SGM
11FEN1
]]>Agencies
[Federal Register Volume 85, Number 28 (Tuesday, February 11, 2020)]
[Notices]
[Pages 7776-7778]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-02671]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Agency Information Collection Activities: Proposed Collection;
Comment Request
In compliance with Section 3506(c)(2)(A) of the Paperwork Reduction
Act of 1995 concerning the opportunity for public comment on proposed
collections of information, the Substance Abuse and Mental Health
Services Administration (SAMHSA) will publish periodic summaries of
proposed projects. To request more information on the proposed projects
or to obtain a copy of the information collection plans, call the
SAMHSA Reports Clearance Officer at (240) 276-0361.
Comments are invited on: (a) Whether the proposed collections of
information are necessary for the proper performance of the functions
of the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use
[[Page 7777]]
of automated collection techniques or other forms of information
technology.
Proposed Project: Mandatory Guidelines for Federal Workplace Drug
Testing Programs (OMB No. 0930-0158)--Revision
SAMHSA will request OMB approval for a revision of the Federal Drug
Testing Custody and Control Form (CCF) for federal agency and federally
regulated drug testing programs which must comply with the HHS
Mandatory Guidelines for Federal Workplace Drug Testing Programs using
Urine (UrMG) dated January 23, 2017 (82 FR 7920) and using Oral Fluid
(OFMG) dated October 25, 2019, and OMB approval for information
provided by test facilities (laboratories and Instrumented Initial Test
Facilities, IITFs) for the National Laboratory Certification Program
(NLCP).
The CCF is used by all federal agencies and employers regulated by
the Department of Transportation (DOT) and the Nuclear Regulatory
Commission (NRC) to document the collection and chain of custody of
urine specimens at the collection site, for HHS-certified test
facilities to report results, and for Medical Review Officers (MROs) to
document and report a verified result. SAMHSA allows the use of the CCF
as a paper or electronic form.
The current OMB-approved CCF has an August 31, 2020 expiration
date. SAMHSA has resubmitted the CCF with major content revisions to
the form for OMB approval. These revisions are:
Copies 1-5
Revised Step 1
1. Added ``Collector Contact Info:'' and ``Other'' line (e.g., email)
Revised Step 2
1. Put Urine and Oral Fluid checkboxes above Step 2 for collector to
annotate
2. Expanded to 4 lines for collector entries:
--General entry for Split, Single, or None Provided (same as
current)
--Entries specific to urine collection (moved ``Collector reads
urine temperature within 4 minutes'' here; other entries same as
current)
--Entries specific to oral fluid collection: added ``Split Type''
with checkboxes for Serial, Concurrent, and Subdivided; ``Each Device
Within Expiration Date?'' with checkboxes Yes or No; and Volume
Indicator(s) Observed checkbox)
--Remarks (same as current)
Revised Step 3
1. Edited instruction to state ``collector affixes seal(s) to
bottle(s)/tube(s)''
Revised Step 4 (Collector Section)
1. Edited ``Specimen Bottle(s) Released To'' box to state ``Specimen
Bottle(s)/Tubes(s) Released To''
Copy 1 (Test Facility Copy)
Revised Step 4 (Accessioner Section)
1. Edited ``Specimen Bottle(s) Released To'' box to state ``Specimen
Bottle(s)/Tubes(s) Released To''
2. Added ``Primary/Single Specimen Device Expiration Date'' and ``Split
Specimen Device Expiration Date'' fields for accessioner to annotate
expiration dates of oral fluid collection devices
Revised Step 5a (Certification and Reporting Section)
1. Removed analyte names and checkboxes
2. Repositioned results and checkboxes: Moved REJECTED FOR TESTING,
ADULTERATED, SUBSTITUTED and INVALID RESULT checkboxes; moved POSITIVE
checkbox to be under DILUTE
3. Added line for certifying scientist to record positive analytes and
concentrations, and added ``Analyte(s) in ng/mL'' instruction (aligned
under ``POSITIVE for:'')
Copy 2 (Medical Review Officer Copy)
Revised Step 6 (Donor Section)
1. Edited donor certification statement to state ``specimen bottle/
tubes''
Revised Step 7 (MRO Section--Primary Specimen)
1. Put Urine and Oral Fluid checkboxes above Step 6 for MRO to annotate
Bottom of Copies
Revised Copy 1
1. Edited label/seal at bottom of Copy 1 to allow for modification
(e.g., perforations, label with transparent seal on one side, and
separate label and seal)
Revised Copies 3-5
1. Removed Steps 6 and 7 (MRO sections)
2. Moved Public Burden Statement from the back to the front of the
copies
Additional Edits to Copy 5
1. Moved Privacy Act Statement (for federal employees) from the back to
the front of the copy
2. Removed Instructions for Completing the CCF from the back. SAMHSA
will post instructions for completing the Federal CCF for urine and
oral fluid on their website.
Based upon information from federal agencies and from DOT
concerning their regulated industries, the number of respondents has
increased from 5.4 million to 6.7 million, which increases the total
burden hours by 170,701.8.
Laboratories and IITFs seeking HHS certification under the NLCP
must complete and submit the NLCP application form. The NLCP
application form has not been revised compared to the previous form.
Prior to an inspection, an HHS-certified laboratory or IITF is
required to submit specific information regarding its procedures.
Collecting this information prior to an inspection allows the
inspectors to thoroughly review and understand the testing procedures
before arriving for the onsite inspection. The NLCP information
checklist has not been revised compared to the previous form.
The annual total burden estimates for the CCF, the NLCP
application, the NLCP information checklist, and the NLCP recordkeeping
requirements are shown in the following table.
----------------------------------------------------------------------------------------------------------------
Burden per
Form/respondent Number of Responses per Total number response Annual burden
respondents respondent of responses (hours) (hours)
----------------------------------------------------------------------------------------------------------------
Custody and Control Form: \1\
Donor....................... 6,726,610 1 6,726,610 0.08 538,128.8
Collector................... 6,726,610 1 6,726,610 0.07 378,000
Laboratory.................. 6,726,610 1 6,726,610 0.05 336,330
IITF........................ 1 0 0 0.05 0
Medical Review Officer...... 6,726,610 1 6,726,610 0.05 270,000
NLCP Application Form: \2\
Laboratory.................. 5 5 5 3 15
[[Page 7778]]
IITF........................ 0 0 0 3 0
Sections B and C--NLCP
Inspection Checklist:
Laboratory.................. 29 1 29 1 29
IITF........................ 0 0 0 1 0
Record Keeping:
Laboratory.................. 29 1 29 250 7,250
IITF........................ 0 0 0 250 0
-------------------------------------------------------------------------------
Total................... 6,726,673 .............. 26,906,503 .............. 1,529,753
----------------------------------------------------------------------------------------------------------------
Send comments to Carlos Graham, SAMHSA Reports Clearance Officer,
Room 15-E-57-A, 5600 Fishers Lane, Rockville, MD 20857 OR email a copy
to [email protected]. Written comments should be received by
April 13, 2020.
Jennifer Wilson,
Budget Analyst.
[FR Doc. 2020-02671 Filed 2-10-20; 8:45 am]
BILLING CODE 4162-20-P
